Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Intercept Pharmaceuticals Inc (Symbol: ICPT), where a total volume of 7,148 contracts has been traded thus far today, a contract volume which is representative of approximately 714,800 underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 58% of ICPT's average daily trading volume over the past month, of 1.2 million shares. Particularly high volume was seen for the $22.50 strike call option expiring October 21, 2022, with 2,866 contracts trading so far today, representing approximately 286,600 underlying shares of ICPT. Below is a chart showing ICPT's trailing twelve month trading history, with the $22.50 strike highlighted in orange:
Intrepid Potash Inc (Symbol: IPI) saw options trading volume of 1,507 contracts, representing approximately 150,700 underlying shares or approximately 55.4% of IPI's average daily trading volume over the past month, of 271,790 shares. Especially high volume was seen for the $50 strike call option expiring September 16, 2022, with 226 contracts trading so far today, representing approximately 22,600 underlying shares of IPI. Below is a chart showing IPI's trailing twelve month trading history, with the $50 strike highlighted in orange:
And Oracle Corp (Symbol: ORCL) saw options trading volume of 29,843 contracts, representing approximately 3.0 million underlying shares or approximately 55.3% of ORCL's average daily trading volume over the past month, of 5.4 million shares. Particularly high volume was seen for the $75 strike put option expiring September 16, 2022, with 7,778 contracts trading so far today, representing approximately 777,800 underlying shares of ORCL. Below is a chart showing ORCL's trailing twelve month trading history, with the $75 strike highlighted in orange:
For the various different available expirations for ICPT options, IPI options, or ORCL options, visit StockOptionsChannel.com.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
